Metrowest Health Foundation

Fraxa Research Foundation, based in Newburyport, MA, is dedicated to finding effective treatments and ultimately a cure for Fragile X syndrome, the most common inherited cause of autism and intellectual disabilities. The foundation funds groundbreaking research and clinical trials by partnering with top universities and biomedical companies worldwide, driven by a personal commitment from its staff and board, many of whom are parents of children affected by Fragile X. With a focus on advancing scientific understanding, Fraxa supports various research initiatives, including studies on the NMDA receptor and muscle function in children with Fragile X. The foundation has awarded numerous research grants and collaborates with pharmaceutical partners to bridge the gap between discovery and treatment, aiming to improve the lives of those impacted by Fragile X and related disorders. Generated from the website